Clinical Trials Sponsored by Mirati Therapeutics Inc.
Total 3033 results
-
Mirati Therapeutics Inc.CompletedHealthy AdultsUnited States
-
Mirati Therapeutics Inc.Active, not recruitingClear-Cell Renal Cell CarcinomaUnited States
-
Mirati Therapeutics Inc.CompletedAdvanced Solid TumorUnited States
-
Mirati Therapeutics Inc.CompletedHealthy AdultsUnited States
-
Mirati Therapeutics Inc.CompletedAdvanced CancerKorea, Republic of, United States
-
Mirati Therapeutics Inc.Enrolling by invitationAdvanced or Metastatic Solid MalignanciesUnited States
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced Solid TumorUnited States
-
Mirati Therapeutics Inc.CompletedHealthy AdultsUnited States
-
Mirati Therapeutics Inc.TerminatedAdvanced CancerUnited States
-
Mirati Therapeutics Inc.CompletedAdvanced CancerUnited States, Korea, Republic of, Canada
-
Mirati Therapeutics Inc.CompletedMyelodysplastic SyndromeUnited States
-
Mirati Therapeutics Inc.CompletedUrothelial CarcinomaUnited States
-
Mirati Therapeutics Inc.CompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Mirati Therapeutics Inc.TerminatedAdvanced Malignancies, Non-small Cell Lung CancerUnited States
-
Mirati Therapeutics Inc.CompletedMyelodysplastic Syndromes | LeukemiaUnited States, Canada
-
Mirati Therapeutics Inc.CompletedNon Hodgkin's Lymphoma | TumorsCanada, United States
-
Mirati Therapeutics Inc.CompletedAdvanced MalignanciesUnited States
-
Mirati Therapeutics Inc.RecruitingMetastatic Lung Cancer | Advanced NSCLCUnited States, Spain, Greece, Hungary, France, Italy, Poland
-
Mirati Therapeutics Inc.RecruitingPancreatic Adenocarcinoma | Solid Tumor | Non Small Cell Lung Cancer | Mesothelioma | Advanced Solid Tumor | Malignant Peripheral Nerve Sheath TumorsUnited States
-
Mirati Therapeutics Inc.TerminatedCarcinoma, Non-Small-Cell LungUnited States
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced Non Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States, Australia, France, Italy, Korea, Republic of, Poland, Russian Federation, Spain, United Kingdom, China, Romania, Netherlands, Hong Kong, Austria, Belgium, Czechia, Hungary, Portugal, Greece, Germany, Ireland, Switze... and more
-
Mirati Therapeutics Inc.Active, not recruitingMetastatic Colorectal Cancer | Advanced Colorectal CancerUnited States, Denmark, Finland, Italy, Spain, Belgium, Romania, Taiwan, Thailand, France, Germany, Korea, Republic of, China, Malaysia, Hong Kong, Australia, Austria, Puerto Rico, Singapore, Canada, Portugal, Poland, Greece, United Kingdom and more
-
Mirati Therapeutics Inc.CompletedHealthy AdultsUnited States
-
Mirati Therapeutics Inc.CompletedHepatic ImpairmentUnited States
-
Mirati Therapeutics Inc.Approved for marketingMetastatic Cancer | Advanced Cancer | Malignant NeoplasmUnited States
-
Mirati Therapeutics Inc.CompletedNon-Small Cell Lung CancerUnited States, Korea, Republic of, Hungary, United Kingdom, Italy, Australia, Taiwan, Poland, Canada
-
Mirati Therapeutics Inc.TerminatedHodgkin's LymphomaUnited States, Canada
-
Mirati Therapeutics Inc.CompletedLymphocytic Leukemia, ChronicUnited States, Canada
-
Mirati Therapeutics Inc.CompletedLymphomaUnited States, Canada
-
Mirati Therapeutics Inc.TerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States, Canada, United Kingdom
-
Mirati Therapeutics Inc.TerminatedStomach Cancer | Breast Cancer | Gastric Cancer | Lung Cancer | Prostate Cancer | Non-Small-Cell Lung Carcinoma | Prostatic Cancer | Pulmonary CancerUnited States
-
Mirati Therapeutics Inc.RecruitingMetastatic Cancer | Advanced Cancer | Malignant Neoplasm of LungKorea, Republic of, United States, Turkey, France, Taiwan
-
Mirati Therapeutics Inc.RecruitingPancreatic Adenocarcinoma | Solid Tumor | Advanced Solid Tumor | Non-small Cell Lung Cancer | Colo-rectal CancerUnited States
-
Mirati Therapeutics Inc.RecruitingSolid Tumor | Non Small Cell Lung Cancer | Advanced Solid Tumor | Colo-rectal CancerUnited States, Puerto Rico
-
Mirati Therapeutics Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung CancerUnited States, Korea, Republic of, Italy, Spain, Czechia, Hungary, Netherlands, Canada, Australia, Austria, Belgium, Germany, Ireland, Israel, Poland, United Kingdom, Taiwan, Portugal
-
Mirati Therapeutics Inc.RecruitingMetastatic Cancer | Advanced Cancer | Malignant Neoplastic DiseaseUnited States, Puerto Rico
-
Mirati Therapeutics Inc.CompletedClear Cell Renal Cell CarcinomaUnited States
-
Mirati Therapeutics Inc.TerminatedUrothelial Carcinoma Bladder | Urothelial Carcinoma | Urothelial Carcinoma Ureter | Urothelial Carcinoma of the Renal Pelvis and Ureter | Urothelial Carcinoma UrethraUnited States
-
Mirati Therapeutics Inc.Completed
-
Mirati Therapeutics Inc.TerminatedHodgkin Lymphoma | Non-Hodgkin Lymphoma (Follicular or Large Diffuse B-cell Lymphoma or Mantle Cell Lymphoma)United States
-
Mirati Therapeutics Inc.CompletedTumorsUnited States, Canada
-
Mirati Therapeutics Inc.TerminatedMyelodysplastic Syndromes | Myelogenous Leukemia, AcuteUnited States, Canada
-
Mirati Therapeutics Inc.Completed
-
Mirati Therapeutics Inc.CompletedAdvanced MalignanciesUnited States
-
Mirati Therapeutics Inc.CompletedMyelodysplastic Syndromes | LeukemiaCanada, United States
-
Mirati Therapeutics Inc.NovartisActive, not recruitingMetastatic Cancer | Advanced Cancer | Malignant Neoplastic DiseaseUnited States
-
Verastem, Inc.Mirati Therapeutics Inc.RecruitingNon Small Cell Lung Cancer | Metastatic Cancer | Advanced Cancer | Malignant Neoplasm of Lung | Malignant Neoplastic Disease | KRAS Activating MutationUnited States
-
Mirati Therapeutics Inc.Boehringer IngelheimCompletedMetastatic Cancer | Advanced Cancer | Malignant Neoplasm of Colon | Malignant Neoplasm of Lung | Malignant Neoplastic DiseaseUnited States
-
Kura Oncology, Inc.Mirati Therapeutics Inc.RecruitingNon Small Cell Lung Cancer (NSCLC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Colorectal Cancer (CRC) | Clear Cell Renal Cell Carcinoma (ccRCC) | Solid Tumors With HRAS AlterationsUnited States
-
Mirati Therapeutics Inc.Aadi Bioscience, Inc.RecruitingNSCLC | Metastatic Cancer | Advanced Cancer | Solid Tumor, Adult | Malignant Neoplastic DiseaseUnited States